This study tests whether adding a special ultrasound device called Suizenji to standard chemotherapy helps people with advanced pancreatic cancer that didn't respond to initial treatment. About 90 adults whose cancer cannot be removed by surgery will receive either chemo alone or…
Phase: NA • Sponsor: SONIRE Therapeutics Inc. • Aim: Disease control
Last updated Jun 27, 2026 11:02 UTC